Announced details
Cancer risk assessment, medical institutions, and applications of trace-element analysis technology cultivated in the semiconductor field
Adopted by medical institutions nationwide
An investee of SEIKA CORPORATION’s “VIORB 2030” Long-Term Management Vision SDGs Support Fund.
Head office: Isehara, Kanagawa Prefecture; Representative Director: Kato Kei (加藤 桂). The company has developed an in-house test that applies trace-element analysis technology cultivated in the semiconductor field to assess the risk of cancer in multiple parts of the body using only blood samples.
FY2025 (Reiwa 7) “300 SMEs and Small Businesses to Watch” / Growth Strategy and Productivity Improvement category
Ministry of Economy, Trade and Industry, Small and Medium Enterprise Agency
Isehara, Kanagawa Prefecture
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
株式会社レナテック website (https://www.renatech.net/news/7533/)
| Item | Details |
|---|---|
| Names of Products / Services Covered | Metallo Balance Test (blood-based cancer risk assessment) |
| Counterparty | 株式会社レナテック |
| Counterparty overview | Head office: Isehara, Kanagawa Prefecture; Representative Director: Kato Kei (加藤 桂). The company has developed an in-house test that applies trace-element analysis technology cultivated in the semiconductor field to assess the risk of cancer in multiple parts of the body using only blood samples. |
| Relationship with the Company | An investee of SEIKA CORPORATION’s “VIORB 2030” Long-Term Management Vision SDGs Support Fund. |
| Applicable area | Cancer risk assessment, medical institutions, and applications of trace-element analysis technology cultivated in the semiconductor field |
| Award/certification name | FY2025 (Reiwa 7) “300 SMEs and Small Businesses to Watch” / Growth Strategy and Productivity Improvement category |
| Awarding / certifying body | Ministry of Economy, Trade and Industry, Small and Medium Enterprise Agency |
| Location | Isehara, Kanagawa Prefecture |
| Usage history | Adopted by medical institutions nationwide |
| Source | 株式会社レナテック website (https://www.renatech.net/news/7533/) |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company’s innovative technology and significant contribution to addressing social issues were recognized.